ionis angptl3-lrx
Nucleic acidexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02709850)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Angiopoietin-related protein 3INHIBITOR
ANGPTL3 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ionis angptl3-lrx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02709850 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2015 | Akcea Therapeutics, Ionis Pharmaceuticals, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Akcea Therapeutics | For profit | 1 | 0 | 1 | 2015 |
| Ionis Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1